TY  - JOUR
JF  - BMC Medical Research Methodology
A1  - Sydes, MR
A1  - Manamley, N
A1  - Mallett, S
A1  - Hollis, S
A1  - Scrimgeour, A
A1  - Burger, HU
A1  - Urban, HJ
SN  - 1471-2288
UR  - http://dx.doi.org/10.1186/s12874-016-0172-9
N1  - This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
IS  - Suppl 1
SP  - 37
VL  - 16
KW  - Statistician
KW  -  Clinical trial
KW  -  Data sharing
KW  -  Transparency
KW  -  Pharmaceutical research
KW  -  Biotechnology research
KW  -  Academic research
ID  - discovery1502202
N2  - Greater transparency and, in particular, sharing of clinical study reports and patient level data for further research is an increasingly important topic for the pharmaceutical and biotechnology industry and other organisations who sponsor and conduct clinical research as well as academic researchers and patient advocacy groups. Statisticians are ambassadors for data sharing and are central to its success. They play an integral role in data sharing discussions within their companies and also externally helping to shape policy and processes while providing input into practical solutions to aid data sharing. Data sharing is generating changes in the required profile for statisticians in the pharmaceutical and biotechnology industry, as well as academic institutions and patient advocacy groups.
PB  - BioMed Central
TI  - Data Sharing and the Evolving Role of Statisticians
EP  - 43
AV  - public
Y1  - 2016/08//
ER  -